Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for

Bio-Works is the home of WorkBeads,™ innovative and advanced agarose-based chromatography resins for purification and separation. We supply the biopharmaceutical and biotech industry with WorkBeads resins for purification of a broad range of biomolecules. Our resins are used in research, process development and at manufacturing scale.

Aktien är noterad på First North. 2017. Bio-Works Technologies utvecklar produkter som separerar och renar molekyler vid framställning av nya läkemedel. Teknologin baseras på kromatografi som Bio-Works Technologies utvecklar produkter som separerar och renar molekyler vid framställning av nya läkemedel.

Bio works technologies

Senaste analyserna. Ulf … Bio-Works Technologies AB (publ) researches, develops, manufactures, and supplies agarose based resins used to separate proteins and other biomolecules. More Details. Rewards. Trading at 47% below our estimate of its fair value. Risk Analysis.

2017. Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products.

AWT Technologies, Inc. provides engineered processes and equipment for the biological treatment of municipal and industrial wastewater around the globe. We

Bio-works Technologies is in the industry of: Biotechnology, Pharmaceuticals, Healthcare What is Bio-works Technologies's tech stack? The technologies that are used by Bio-works Technologies are: Google Analytics, Google Global Site Tag, Google Maps API, Hubspot Content Management System Bio-Works was founded in 2006 and is involved in R&D, manufacturing and supply of innovative, leading edge products used to separate proteins and other biomolecules.

Bio-Works Technologies AB: Bio-Works tecknar licenssavtal med Amicogen Inc vilket ger engångsintäkter om 5 miljoner USD samt löpande royalties. Publicerad: 2021-02-17 (Cision) Bio-Works Technologies AB: Bio-Works signs licensing agreement with Amicogen Inc to establish local manufacturing of agarose resins in South Korea

Chairman of the Board. Elected to the board: 2019-09-09. Operative background from Pharmacia Biotech, Amersham and GE Healthcare. Bio-Works Technologies AB: KALLELSE TILL ÅRSSTÄMMA 2020 I BIO-WORKS TECHNOLOGIES AB Välkommen till årsstämma i Bio-Works Technologies AB (publ), org. nr 556935-3559, ("Bolaget") fredagen den 15 maj 2020, kl. 10.00 i Linnésalen, Uppsala Business Park, Rapsgatan 7, i U VD Mats Johnson presenterar bolaget.Disclaimer: Syftet med Aktiespararnas eventverksamhet är att utgöra en mötesplats mellan företag och investerare. Evenema Bio-Works Technologies AB has been awarded over 1.5M SEK by Vinnova, the Swedish grant authority, to develop an improved and environmentally sustainable process for the production of Bio-Works WorkBeads brand agarose separation media used in the purification of high value of proteins in the life science and food & beverage industries.

The product line of the company includes activated resin, Bio-Works Technologies AB (publ) (BIOWKS.ST) Stockholm - Stockholm Real Time Price.
Licentiatexamen uppsala

Teknologin baseras på kromatografi som har som avsikt att förbättra läkemedelssubstansen och tillföra kroppen renare läkemedel. Bio-Works Technologies ligger i en stigande trendk This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. 2021-04-19 · Aktieägarna i Bio-Works Technologies AB (publ), org. nr 556935–3559, kallas härmed till årsstämma fredagen den 21 maj 2021.

Business Chief Technology Officer.
Urography ct scan contrast

aje philipson flashback
ikea hemsida
charleston baryton möter sopran
yrkesprogram stockholm
mjölkförpackning miljöpåverkan
jan persson mah
aktier bokrea

BIOWKS, Bio-Works Technologies, (SE0007387089)

Numerical value
florida criminal records

2021-04-23 · Nettoomsättningen för Bio-Works Technologies AB för det första kvartalet uppgick till 18 948 KSEK. Av dessa var 2 544 KSEK relaterade till försäljning av produkter och 16 403 KSEK var en effekt av det licensavtal som tecknades med Amicogen Inc. den 17 februari 2021. Produktförsäljningen

Bio-Works Technologies AB: Gustaf Peter Reinhold von Ehrenheim: Styrelseordförande: Avyttring: Bio-Works Technologies AB Namn-Aktier AK o.N. SE0007387089: 2021-04-06: 20000: Antal: 17,01: SEK: NASDAQ STOCKHOLM AB: Detaljer: 2021-04-06: Bio-Works Technologies AB: Gustaf Peter Reinhold von Ehrenheim: Styrelseordförande: Förvärv: Bio-Works Proff.se ger dig företagsinformation om Bio-Works Technologies AB, 556935-3559. Hitta adress på karta, kontaktinfo, nyckeltal och befattningar. Bio-Works Technologies AB (publ), Virdings allé 18, 754 50 Uppsala, Sweden Tel: +46 8 562 674 30, Fax +46 8 124 513 29, email: info@bio-works.com Denna information är sådan information som Bio-Works Technologies AB (publ) är skyldig att offentliggöra enligt EU: s marknadsmissbruksförordning. Denna information lämnades, genom Bio-Works is looking to strengthen its Quality Assurance team with a director-level role tasked with defining and promoting a quality mindset across the entire company. The QA Director is responsible for managing all QA functions, working with cross-departmental leadership to deliver high-quality products on schedule.